Babcock & Wilcox Enterprises, Inc. (NYSE: BW) provides fossil and renewable power generation and environmental equipment for the power and industr...
Digital Power, Growth Through Acquisition and Innovation in Bitcoin Mining
PR Excerpt December, 2017 "Both digital mining as an industry and cryptocurrency as an asset class have experienced exponential growth for the past 5 ...
ImmunoGen, Q2 Results, Analyst Targets and Pipeline Review
ImmunoGen, Inc. (NASDAQ: IMGN) is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its antibody-drug conjugate ...
Zynerba Pharmaceuticals Upcoming Catalysts and Price Target
Zynerba Pharmaceuticals (NASDAQ: ZYNE) Zynerba Pharmaceuticals (NASDAQ: ZYNE) is a clinical-stage specialty pharmaceutical company focused on devel...
Encana Analyst Coverage and Price Target
Encana Corporation (NYSE: ECA) is an energy producer that is focused on developing its multi-basin portfolio of natural gas, oil and natural gas liqui...
Moleculin Updates Annamycin Progress and Full Pipeline Review
Moleculin Biotech, Inc, (NASDAQ: MBRX) is a preclinical stage pharmaceutical company focused on the development of anti-cancer drug candidates, some o...
Sprint, Encouraging Quarterly Results with Multiple Potential Transactions in the Works
Company Overview Sprint Corporation (NYSE: S) is a communications company that offers both wireless and wireline products and services to consumers, b...
Potential Market Size for CHF Solutions Aquadex FlexFlow System
CHF Solutions, Inc. (NASDAQ: CHFS) CHF Solutions, Inc. (NASDAQ: CHFS) is an early-stage medical device company focused on commercializing the Aquadex ...
Micronet Enertec Technologies Analysis ahead of Q2 2017 Earnings Release
Overview Micronet Enertec Technologies, Inc. (NASDAQ: MICT) operates through two subsidiaries, Enertec Systems, a wholly-owned subsidiary and Micron...
Cleveland Biolabs Countermeasure for Acute Radiation Syndrome Receives Approval for In Vivo Comparability Study
Company Overview Cleveland BioLabs, Inc. (NASDAQ: CBLI) is a biopharmaceutical company engaged in the development of techniques to activate the immune...